Remove Definition Remove Pharmacokinetics Remove Small Molecule
article thumbnail

The rising impact of biomarkers in early clinical development

Drug Target Review

4 The definition has since evolved and expanded to include molecular signatures of pharmacodynamics and therapeutic response. Novel mechanisms of action associated with CGTs naturally create dosing effects that apply in very different ways than with traditional small molecule pharmacotherapies. 21(10):3517. Rodrigues AD.

article thumbnail

Re-Imagining Med Chem Strategies: the Tyranny of the n+1 Compound

DrugBaron

Finding small molecule drugs is much harder than finding a needle in a haystack – discovering the right arrangement of atoms to bind precisely to a protein target to elicit a particular response is a problem of vast dimensionality. Yet the situation with small molecules is even worse.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AI in Drug Discovery - A Highly Opinionated Literature Review (Part II)

Practical Cheminformatics

When given the prompt “Please estimate the binding affinity between the drug Afatinib and target EGFR”, GPT-4 suggested a docking study, which is definitely not a wise choice. These fingerprint bits then map to atom environments or bond paths, which often don’t correspond to widely accepted functional group definitions.

Drugs 136
article thumbnail

Building collaborations to fight a pandemic

The Pharma Data

Novartis has agreed to contribute a carefully curated library of about 1300 small molecules with antiviral activity to the CARE project. We are also supporting the consortium’s preclinical safety and pharmacokinetics workstreams. I guess that’s the true definition of situational leadership.

Virus 52
article thumbnail

Analysis Life Sciences Thank You FDA’s new guidance on postapproval manufacturing changes for biosimilars focuses on current practice, new dosage forms

Agency IQ

in equipment) for products that are more complex or aren’t as well-characterized, such as antibody drug conjugates or recombinant DNA products, will be considered higher risk than they would if the change was made to the production of standard, small molecule products. Any CMC changes (e.g.,

article thumbnail

Analysis Life Sciences Thank You FDA finalizes new guidance on nonclinical assessment of potential immunotoxicity

Agency IQ

However, this guideline is primarily intended to provide recommendations on evaluating the immune system’s response to small molecule drugs. It also contains a definition of the term immunotoxicity— the unintended immunosuppression or stimulation (including hypersensitivity) —which was notably absent from the draft.

FDA 40
article thumbnail

Analysis Life Sciences Thank You The FDA and oncology: 2023 year in review

Agency IQ

In 2015, the FDA, along with the American Association for Cancer Research (AACR), held a workshop on dose optimization for small molecules. Just a few months ago, OCE Associate Director HARPREET SINGH noted , “I know definitely for older adults… there’s not enough work done.”

FDA 40